U.S. pharma giant copyright scrapped two experimental weight loss supplements final yr—a once-everyday pill, lotiglipron, due to elevated liver enzymes and a twice-daily capsule, danuglipron, resulting from strong Unwanted side effects—but CEO Albert Bourla has reported the company is set to “Enjoy and earn” from the weight problems Place a